Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bioharvest Sciences Inc C.BHSC

Alternate Symbol(s):  BHST

BioHarvest Sciences Inc. is a Canada-based biotechnology company. The Company offers Botanical Synthesis, its patented technology process to grow plant-based molecules, without the need to grow the underlying plant. The Company is leveraging its Botanical Synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business verticals: as a contract development and production organization (CDMO) on behalf of customers seeking complex molecules, and as a creator of proprietary nutraceutical health and wellness products, which includes dietary supplements. The Company operates through two segments: Nutraceuticals and Pharmaceuticals. The Company offers a polyphenol/antioxidant superfruit product called VINIA, which is a red grape powder that supplies the benefits of red wine consumption but without the sugar, calories and alcohol found in wine.


CSE:BHSC - Post by User

Post by Betteryear2on Feb 16, 2022 6:49pm
244 Views
Post# 34435796

Trademarks Breakthrough Non-GMO Proven Platform Technology

Trademarks Breakthrough Non-GMO Proven Platform Technology

New name to reflect the Biotech power of combining plant cell growth with elicitation of specific molecules to produce unique compounds of high human utility value

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - February 16, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or "the Company") has announced the new trademark for its proprietary non-GMO Biotech platform technology. The new name, "Bio-Plant CELLicitation™," replaces "BioFarming" and underscores the potential for the technology to be used in the botanical drugs space.

"The Bio-Plant CELLicitation™ proven platform technology allows us to address multiple market verticals with multiple products under different categories," said CEO Ilan Sobel. "The elicitation element allowing the creation of patentable compounds that can be produced economically and consistently with cleanliness and high sustainability credentials, enables BioHarvest to potentially impact the botanical drugs market in addition to growing its core base business."

The CEO added, "the term CELLicitation™ better reflects the combined actions of growing plant cells in industrial-scale bioreactors while eliciting specific molecules and/or structures in order to produce unique botanical compounds with high human utility value."


<< Previous
Bullboard Posts
Next >>